Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis

Background: Real world evidence data regarding secukinumab (SEC) use in biologic-experienced patients with psoriatic arthritis (PsA) are scarce. Objectives: To assess the real life survival, safety and efficacy of SEC in biologic-experienced patients with PsA. Methods: All biologic-experienced PsA p...

Descripción completa

Detalles Bibliográficos
Autores principales: Klavdianou, Kalliopi, Lazarini, Argyro, Grivas, Alexandros, Tseronis, Dimitrios, Tsalapaki, Christina, Rapsomaniki, Panagiota, Antonatou, Katerina, Thomas, Konstantinos, Boumpas, Dimitrios, Katsimbri, Pelagia, Vassilopoulos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317305/
https://www.ncbi.nlm.nih.gov/pubmed/32637422
http://dx.doi.org/10.3389/fmed.2020.00288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317305/
https://www.ncbi.nlm.nih.gov/pubmed/32637422
http://dx.doi.org/10.3389/fmed.2020.00288

Ejemplares similares